2026 NPPES data Pharmacotherapy Pharmacist NPI 1760459903 PHARMD, MD
Verify on CMS →

MAYA GARALA, PHARMD, MD

Pharmacotherapy Pharmacist in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
109
Medicare Part D claims · 44 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$124.98
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MAYA GARALA, PHARMD, MD is a Pharmacotherapy Pharmacist ([object Object]) practicing in BROOKLYN, New York with a Medicare Part D prescribing footprint of 109 claims across 44 beneficiaries — 12% brand-name prescribing . Industry payments of $124.98 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MAYA GARALA, PHARMD, MD filed 109 Medicare Part D claims in 2023 across BROOKLYN, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MAYA GARALA, PHARMD, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/07/2006

NPI 1760459903

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

109 73% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in New York

How Pharmacotherapy Pharmacist compares to other specialties among New York providers

New York providers

Pharmacotherapy Pharmacist share within New York

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAYA GARALA, PHARMD, MD is a Pharmacotherapy Pharmacist provider practicing in BROOKLYN, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD, MD. NPI: 1760459903. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MAYA GARALA, PHARMD, MD appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARMD, MD credentials at 404 E 16TH ST, BROOKLYN, NY, 11226, with a listed phone of (917) 749-9167. NPI 1760459903 was issued on 03/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GARALA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 109 prescription claims written by this provider, covering 44 Medicare beneficiaries and totaling roughly $4K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 16.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

404 E 16TH ST
BROOKLYN, NY 11226

Provider Details

NPI 1760459903
Specialty Pharmacotherapy Pharmacist
Credentials PHARMD, MD
Gender Female
NPI Issued 03/07/2006

Hospital and facility affiliations

Facilities where MAYA GARALA, PHARMD, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NORTH SHORE - LIJ ANESTHESIOLOGY, PC
BAY SHORE, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MAYA GARALA, PHARMD, MD. Source: openpaymentsdata.cms.gov.

Total received

$125

Largest payer

Janssen Pharmaceuticals, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MAYA GARALA, PHARMD, MD. To verify MAYA GARALA, PHARMD, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MAYA GARALA, PHARMD, MD — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 109 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

109
Total Claims
$4K
Total Drug Cost
44
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
109
Total Day Supply
2,797
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$3K
Generic Drug Cost
$1K
Opioid Claims
18 (16.5% rate)

Patient Demographics

Average Patient Age
82.1 years
Avg HCC Risk Score
2.97
Gender Split
55% female / 45% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How MAYA GARALA, PHARMD, MD fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

MAYA GARALA, PHARMD, MD's 109 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GARALA.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAYA GARALA, PHARMD, MD's specialty?
MAYA GARALA, PHARMD, MD specializes in Pharmacotherapy Pharmacist and practices in BROOKLYN, New York. Credentials: PHARMD, MD.
How much does MAYA GARALA, PHARMD, MD prescribe under Medicare Part D?
In 2023, MAYA GARALA, PHARMD, MD wrote 109 Medicare Part D claims totaling $4K in drug costs for 44 beneficiaries.
Where is MAYA GARALA, PHARMD, MD located?
MAYA GARALA, PHARMD, MD is located at 404 E 16TH ST, BROOKLYN, NY, 11226. Phone: (917) 749-9167.
What is MAYA GARALA, PHARMD, MD's NPI number?
MAYA GARALA, PHARMD, MD's National Provider Identifier (NPI) is 1760459903, issued on 03/07/2006.
Does MAYA GARALA, PHARMD, MD prescribe more brand-name or generic drugs?
MAYA GARALA, PHARMD, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $3K in brand drug costs.
Does MAYA GARALA, PHARMD, MD prescribe opioids?
Yes, MAYA GARALA, PHARMD, MD had 18 opioid claims in 2023 with an opioid prescribing rate of 16.5%.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does MAYA GARALA, PHARMD, MD prescribe most often?
Based on 2023 Medicare Part D data, MAYA GARALA, PHARMD, MD's most frequently prescribed drugs include Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAYA GARALA, PHARMD, MD accept Medicare?
MAYA GARALA, PHARMD, MD appears in CMS Medicare data with 109 Part D claims and 44 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAYA GARALA, PHARMD, MD's credentials?
MAYA GARALA, PHARMD, MD's NPI is 1760459903 with credentials PHARMD, MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology